Unravelling the transcriptomic landscape of the major phase II UDP-glucuronosyltransferase drug metabolizing pathway using targeted RNA sequencing.


  • Date de publication : 2016-01-29

Référence

Tourancheau A, Margaillan G, Rouleau M, Gilbert I, Villeneuve L, Lévesque E, Droit A, Guillemette C. Unravelling the transcriptomic landscape of the major phase II UDP-glucuronosyltransferase drug metabolizing pathway using targeted RNA sequencing. Pharmacogenomics J. 2016;16:60-70. doi: 10.1038/tpj.2015.20. PubMed PMID: 25869014.

Information Complémentaire

Lien vers PubMed

Mot(s) Clé(s)

breast breast neoplasms endometrium female glucuronosyltransferase humans intestinal neoplasms intestines kidney kidney neoplasms liver liver neoplasms male metabolic detoxication, phase ii organ specificity prostate prostatic neoplasms rna, messenger sequence analysis, rna transcriptome uterine neoplasms

Résumé

Retour